Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs GE HealthCare Technologies Inc. Common Stock — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.23 (market cap $12.90B), while GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2.4× iShares JPMorgan USD Emerging Markets Bond ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none. Which is the better fit depends on your goals.
| EMB | GEHC | |
|---|---|---|
Market Cap | $12.90B | $31.07B |
Volume | 8,768,615 | 3,443,020 |
Sector | Fixed Income | Health |
52-Week High | $97.74 | $88.16 |
52-Week Low | $90.14 | $59.48 |
Typical Hold Time | 50 Days | — |
Enterprise Value | — | $39.53B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $91.26, up 0.2% on the day, with technical indicators showing a bearish bias as moving averages signal selling pressure. The stock faces resistance near $91-92 while support holds at $90. Recent corporate actions include scheduled dividend payments through October 2026, though key valuation metrics remain unavailable for fundamental assessment.
The outlook remains cautious given the bearish technical setup and limited fundamental visibility. Investment opportunity hinges on future financial disclosures, while risks include market volatility from rising bond yields and emerging market exposure. Analyst sentiment suggests EMB's returns will primarily come from yield rather than price appreciation.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
